Jan 26 (Reuters) - MedAvail Holdings Inc MDVL.O :
* MEDAVAIL ANNOUNCES SALE OF PHARMACY ASSETS TO CVS PHARMACY
* MEDAVAIL HOLDINGS - PORTION OF PROCEEDS FROM CVS
TRANSACTION
WILL BE USED TO PAYDOWN COMPANY'S EXISTING LOAN FACILITY
* MEDAVAIL HOLDINGS INC - PORTION OF PROCEEDS FROM CVS
TRANSACTION
WILL BE USED TO PAYDOWN COMPANY'S EXISTING LOAN FACILITY
* MEDAVAIL HOLDINGS INC - REMAINING PROCEEDS WILL BE USED
FOR
ONGOING OPERATION OF COMPANY
* MEDAVAIL HOLDINGS INC - CO CURRENTLY ESTIMATES IT WILL
END
2022, PRIOR TO CVS TRANSACTION, WITH BETWEEN $10 MILLION TO $11
MILLION OF CASH AND INVESTMENTS
* MEDAVAIL HOLDINGS INC - ESTIMATES THAT IT WILL END 2022,
PRIOR
TO CVS TRANSACTION, WITH BETWEEN $10 MILLION TO $11 MILLION OF
CASH AND INVESTMENTS
* MEDAVAIL HOLDINGS INC - CONTINUES TO CLOSELY EVALUATE
VARIOUS
FINANCINGS OPTIONS, INCLUDING WITH EXISTING SHAREHOLDERS
* MEDAVAIL HOLDINGS - CURRENTLY ESTIMATES WILL INCUR
ONE-TIME
COSTS IN H1 2023 RELATED TO RESTRUCTURING TO BE ABOUT $6.5
MILLION
* MEDAVAIL HOLDINGS INC - PHARMACY RECORDS AND INVENTORY
PURCHASED
BY CVS WILL BE TRANSFERRED FROM SPOTRX PHARMACIES TO NEARBY CVS
PHARMACY LOCATIONS
Source text for Eikon: ID:nGNXhjtzk
Further company coverage: MDVL.O
((Reuters.Briefs@thomsonreuters.com;;))